Compare · ENOV vs ISRG
ENOV vs ISRG
Side-by-side comparison of Enovis Corporation (ENOV) and Intuitive Surgical Inc. (ISRG): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ENOV and ISRG operate in Industrial Specialties (Health Care), so they compete in similar markets.
- ISRG is the larger of the two at $151.15B, about 135.5x ENOV ($1.12B).
- ENOV has been more active in the news (4 items in the past 4 weeks vs 3 for ISRG).
- ISRG has more recent analyst coverage (25 ratings vs 20 for ENOV).
- Company
- Enovis Corporation
- Intuitive Surgical Inc.
- Price
- -
- -
- Market cap
- $1.12B
- $151.15B
- 1M return
- +10.26%
- -
- 1Y return
- -37.61%
- -
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NASDAQ
- IPO
- 2000
- News (4w)
- 4
- 3
- Recent ratings
- 20
- 25
Enovis Corporation
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.
Intuitive Surgical Inc.
Intuitive Surgical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets da Vinci surgical systems, and related instruments and accessories in the United States and internationally. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D HD vision systems, skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures. It also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures; and provides SimNow, a cloud-enabled simulation platform, which allows surgeons to learn and practice their surgical skills; Iris, an augmented reality imaging product for use in kidney procedures; and Intuitive Cloud that enables proactive monitoring and software updates. In addition, the company offers EndoWrist Stapler, a wristed stapling instrument for resection, transection, and creation of anastomoses; EndoWrist One Vessel Sealers that are wristed single-use instruments for bipolar coagulation and mechanical transection of vessels up to 7mm in diameter and tissue bundles that fit in the jaws of the instrument; E-100 generator, an electrosurgical generator; SureForm 45 Curved-Tip stapler; and SynchroSeal for sealing and transection with a single pedal press. Additionally, the company sells various accessories comprising sterile drapes for ensuring sterile field during surgery; and vision products that include replacement 3D stereo endoscopes, camera heads, light guides, and other items that facilitate the use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies. Intuitive Surgical, Inc. was founded in 1995 and is headquartered in Sunnyvale, California.
Latest ENOV
- Enovis to Host Third Quarter 2026 Results Conference Call on November 5th
- Director Ortiz Christine was granted 958 shares, increasing direct ownership by 4% to 26,815 units (SEC Form 4)
- Nyxoah Appoints Liam Kelly as Chief Executive Officer
- Enovis becomes first multi-registry industry sponsor of AAOS Registry Program
- Chief Administrative Officer Engert Oliver bought $50,008 worth of shares (2,660 units at $18.80), increasing direct ownership by 4% to 63,898 units (SEC Form 4)
- Chief Executive Officer Mcdonald Damien bought $249,620 worth of shares (13,035 units at $19.15), increasing direct ownership by 6% to 247,077 units (SEC Form 4)
- Chief Administrative Officer Engert Oliver bought $149,971 worth of shares (7,598 units at $19.74), increasing direct ownership by 14% to 61,238 units (SEC Form 4)
- eCential Robotics Announces Binding Offer from Enovis
- Enovis Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Enovis Invests in Innovation with Binding Offer to Acquire eCential Robotics, a Leading Developer of Enabling Technologies and Surgical Robotics
Latest ISRG
- SEC Form 4 filed by Intuitive Surgical Inc.
- SEC Form 4 filed by Intuitive Surgical Inc.
- Barclays initiated coverage on Intuitive Surgical with a new price target
- VP Corporate Controller Widman Fredrik exercised 1,089 shares at a strike of $94.52 and sold $407,765 worth of shares (1,089 units at $374.44) as part of a pre-agreed trading plan (SEC Form 4)
- EVP & Chief Mfg and Supply Cha Brosius Mark sold $17,141 worth of shares (48 units at $357.10) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 764 units (SEC Form 4)
- EVP & Chief Mfg and Supply Cha Brosius Mark sold $24,671 worth of shares (69 units at $357.55) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 812 units (SEC Form 4)
- New meta-analysis shows statistically significant improvements in patient outcomes associated with da Vinci surgery versus laparoscopic and open surgery across 13 common benign conditions
- EVP & Chief Mfg and Supply Cha Brosius Mark sold $59,439 worth of shares (154 units at $385.97) as part of a pre-agreed trading plan, decreasing direct ownership by 15% to 881 units (SEC Form 4)
- EVP & Chief Mfg and Supply Cha Brosius Mark sold $90,778 worth of shares (231 units at $392.98) as part of a pre-agreed trading plan, decreasing direct ownership by 18% to 1,035 units (SEC Form 4)
- Industrial Robot Installations Hit Record Highs as Global Labor Shortages Deepen